IceCure Medical (ICCM) FCF Margin (2020 - 2026)

IceCure Medical (ICCM) has 7 years of FCF Margin data on file, last reported at 463.23% in Q1 2026.

• On a quarterly basis, FCF Margin rose 9291.0% year-over-year to 463.23% in Q1 2026; TTM through Mar 2026 was 413.07%, a 550.0% increase from a year earlier, with the FY2025 full-year figure at 430.25%, down 5066.0% from the prior year.
• FCF Margin for Q1 2026 stood at 463.23%, down from 392.03% in the prior quarter.
• Over the last five years, FCF Margin for ICCM reached as high as 233.14% in Q2 2024 and fell as low as 997.25% in Q3 2023.
• Historically, FCF Margin has averaged 459.08% across 5 years, with a median of 449.15% in 2022.
• Across the five-year window, FCF Margin tumbled 52075 bps in 2023 and surged 52580 bps in 2024, its largest moves.
• Year by year, FCF Margin stood at 618.74% in 2022, then jumped by 59 bps to 253.63% in 2023, then sank by 89 bps to 478.86% in 2024, then advanced by 18 bps to 392.03% in 2025, then decreased by 18 bps to 463.23% in 2026.
• Per Business Quant data, the three most recent FCF Margin figures were 463.23% in Q1 2026, 392.03% in Q4 2025, and 317.88% in Q3 2025.